Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review).
Zhu GX, Gao D, Shao ZZ, Chen L, Ding WJ, Yu QF.
Molecular medicine reports. 2021; 23(2): 1

Abstract

Colorectal cancer (CRC) is the third most common malignant tumor in humans. Chemotherapy is used for the treatment of CRC. However, the effect of chemotherapy remains unsatisfactory due to drug resistance. Growing evidence has shown that the presence of highly metastatic tumor stem cells, regulation of noncoding RNAs and the tumor microenvironment contributes to drug resistance mechanisms in CRC. Wnt/betacatenin signaling mediates the chemoresistance of CRC in these three aspects. Therefore, the present study analyzed the abundant evidence of the contribution of Wnt/betacatenin signaling to the development of drug resistance in CRC and discussed its possible role in improving the chemosensitivity of CRC, which may provide guidelines for its clinical treatment.



P A G E S

Home
Journals
Keywords

P A R T N E R S

ScopeMed
BiblioMed
eJManager

Privacy Policy | citeindex.org © 2021
ScopeMed Web Sites